Diabetes
-
Vanderbilt researchers find that diabetes drug could be effective in treating addiction
A drug already used for the medical management of diabetes also reduces the rewarding effects of cocaine in animals, which could have far-reaching implications for patients worldwide who suffer from addiction. Read MoreOct 23, 2012
-
VUCast: Home Run for Health
This week on VUCast: They won our hearts. Now, learn how one champion is winning his fight with diabetes. Some Vanderbilt classes are soon coming to a computer near you. And, Popeye was right. Researchers give new meaning to the term spinach power. [vucastblurb]… Read MoreSep 19, 2012
-
National type I diabetes prevention trial now an option for younger children
A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old. Read MoreJul 31, 2012
-
It’s his metabolism: Research into cell processes could lead to breakthroughs for diabetes and cancer
Jamey Young, assistant professor of chemical and biomolecular engineering, likes to build bridges. But rather than physical structures, Young focuses on spanning the divide between biology and engineering, diabetes and cancer, and plants and animals. Read MoreJul 2, 2012
-
Vanderbilt and affiliates receive $18.8 million HHS innovation award
The Health Care Innovation Award from the Centers for Medicare and Medicaid Services (CMS) is one of the largest federal research grants awarded to VUMC investigators. The funding will support the implementation and evaluation of MyHealthTeam, a model of team-based care that couples collaborative health care teams with health information technology in order to improve control of chronic conditions. Read MoreJun 18, 2012
-
Family members can often sabotage diabetes care: study
Nonsupportive family members contribute to poor adherence to medication regimens and lower glycemic control in adults with diabetes. Read MoreJun 15, 2012
-
Mixed results define 2012 Tennessee Men’s Health Report Card
Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card. Read MoreJun 12, 2012
-
Beta cell imaging could help spot diabetes earlier
Vanderbilt researchers have developed a biomarker for beta cells that could make it easier to detect diabetes earlier. Read MoreMay 23, 2012
-
Targeting post-transplant diabetes
Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes. Read MoreApr 12, 2012
-
New York Times: Study says DNA’s power to predict illness is limited
Vanderbilt University is already doing genetic analyses of patients to help in developing a shortlist of effective drugs, says Dr. William Schaffner, chairman of the department of preventive medicine at its medical school. Read MoreApr 3, 2012
-
Vanderbilt uses first FDA-approved stent for heart patients with diabetes
Vanderbilt Heart recently used a newly approved medical device to open narrowed coronary arteries, even in heart disease patients who also have diabetes. Read MoreMar 28, 2012
-
Obesity turns “good” cholesterol bad
Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol. Read MoreMar 21, 2012
-
Early study hints at ‘brown fat’ as potential diabetes treatment
A new study finds long-lasting reversal of diabetes is possible without insulin through transplantation of brown fat tissue. Read MoreMar 2, 2012
-
Pumping up the pancreas in pregnancy
A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications. Read MoreJan 20, 2012
-
Diabetes trial sets bar high for retaining research subjects
Research participant Loren Kirkpatrick, right, has worked with Janie Lipps, MSN, and Vanderbilt’s Diabetes Control and Complications Trial since its inception in 1983. (Daniel Dubois / Vanderbilt) Loren Kirkpatrick has been enrolled in the Diabetes Control and Complications Trial (DCCT) at Vanderbilt’s Diabetes Center for nearly half… Read MoreJan 5, 2012
-
Exercise fights fatty liver
(iStock) Fatty liver, a reversible condition of fat accumulation in liver cells, can result from excessive alcohol consumption, obesity, type 2 diabetes, or metabolic disorders. Exercise can reverse this process, but the mechanisms underlying this effect are not clear. Because exercise is known to stimulate the action of glucagon (a… Read MoreNov 18, 2011
-
Growth factor boosts beta cells
A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read MoreOct 21, 2011
-
Initiative to help ‘translate’ diabetes research advances
The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read MoreOct 21, 2011
-
Impact of diabetes, obesity on glioma patients studied
A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding. Read MoreSep 15, 2011
-
VUCast: Future diabetes vaccine?
Vanderbilt leads the nation in a breakthrough drug study that may prevent type-1 diabetes! Plus, how studying the brain could impact criminal law. And a special tribute on the anniversary of 9/11. [vucastblurb]… Read MoreSep 12, 2011